Neuroscientists have decoded how visual cues reorganize the activity of compass neurons in fruit flies to maintain an accurate sense of direction. Tracking individual neurons as flies navigate a virtual reality environment, they shed light on how organisms build a spatial map of their world.
How do we perceive our environment? What is the influence of sensory stimuli on the peripheral nervous system and what on the brain?
Shravani Mikkilineni, M.D., MBA, resident physician in Henry Ford Health System’s Department of Ophthalmology, was recognized among the top five honorees in the third-annual Ophthalmology Times® Research Scholar Honoree Program, earning first place for her presented research, “T2 Magnetic Resonance Assay for Detection of Ocular Candidiasis.”
Researchers at the National Eye Institute used artificial intelligence to evaluate stem cell-derived “patches” of retinal pigment epithelium tissue for implanting into the eyes of patients with age-related macular degeneration, a leading cause of blindness.
The Association for Research in Vision and Ophthalmology (ARVO) and the Eye Bank Association of America (EBAA) today announced a new grant program that will provide financial support to researchers seeking to use human eye tissue in their work.
The Virginia Murray Sowell Center for Research and Education in Sensory Disabilities at Texas Tech University will train scholars as teachers of students with visual impairments, or orientation and mobility specialists, and allow them to complete a master’s degree in special education.
New research discovered that tocilizumab is more effective than rituximab in achieving low disease activity in patients with rheumatoid arthritis whose synovial tissue show a low level of B cell infiltration and did not respond to conventional synthetic disease-modifying anti-rheumatic drugs (conventional synthetic DMARDs) or tumor necrosis factor (TNFi) inhibitors first (Abstract# 2911).
Awards were presented to Philadelphia Mayor Jim Kenney; Thomas Jefferson University President and Jefferson Health CEO, Stephen Klasko, MD, MBA; Benefactor Steven H. Korman and Wills Eye Alumnus and Surgeon-Scientist, Jay Duker, MD
Study is the first to identify specific cellular toxicity and show improvement after stopping supplement use
The American Academy of Ophthalmology is urging people to buy decorative contact lenses only from retailers who require a prescription and sell FDA-approved products.
The 2019-2020 Senior Capstone in Engineering (SCOPE) program officially got underway in September. Fourteen corporate partners have signed on to sponsor SCOPE teams made up of Olin seniors. It is SCOPE’s fifteenth year. The sponsors include: Amazon Robotics, Arthur G. Russell, Boeing, Boston Scientific, CUAHSI, Ford Motor, GE Healthcare, Microsoft, Pfizer, Santos Family Foundation, Sonos, Toyota, Valve Corp and Watts Water Technologies.
Georgetown neuroscientists say they have identified how people can have a “crash in visual processing” — a bottleneck of feedforward and feedback signals that can cause us not to be consciously aware of stimuli that our brain recognized.
Wills Eye Hospital today announced its Ophthalmologist-in-Chief, Julia A. Haller, MD, has been elected to the National Academy of Medicine (NAM), considered one of the highest honors in the fields of health and medicine, recognizing individuals who have demonstrated outstanding professional achievement and commitment to service.
Results from a clinical trial funded by the National Eye Institute (NEI) show that while vision therapy can successfully treat convergence insufficiency (CI) in children, it fails to improve their reading test scores.
Registration is now open for the 11th The Eye and The Chip research congress, which will take place Nov. 10-12, 2019 at The Henry Hotel in Dearborn, Michigan. This year’s research congress will focus on the relationship between neurobiology and nanoelectronics with respect to artificial vision. The ultimate goal of the research congress is to advance progress toward artificial vision for many people who suffer from blindness.
Krzysztof Palczewski, the Irving H. Leopold Chair in Ophthalmology and a professor of physiology & biophysics at the University of California, Irvine, has been elected to the National Academy of Medicine, one of the highest distinctions accorded to professionals in the medical sciences, healthcare and public health.
Rutgers University has launched the nation’s first peer support helpline for the legally blind and their families.
Researchers from Massachusetts Eye and Ear, Harvard Medical School and a team of EPFL researchers have developed a conformable electrode implant that will allow people with a dysfunctional inner ear to hear again. This new technology would improve existing auditory brainstem implants, which have a number of shortcomings.
Researchers at the IU School of Optometry have used adaptive optics technology to create the first undistorted microscopic images of the eye's trabecular meshwork, which could help improve treatment for glaucoma.
New research shows that an automated, artificial intelligence (AI) screening system accurately detects diabetic retinopathy 95.5 percent of the time.
The American Academy of Ophthalmology is honoring ophthalmologists who have improved eye care for millions worldwide through their commitment to their patients and their profession.
A drug widely prescribed for a bladder condition for decades now appears to be toxic to the retina, the light-sensing tissue at the back of the eye that allows us to see.
Researchers in Australia used a driving simulator to test patients’ vision before and after cataract surgery.
Combining two different treatment methods to slow the progression of myopia may deliver better results in slowing the progression of myopia.
Gene therapy is showing promise for one of the most common causes of blindness.
Researchers at the University of Illinois at Chicago are the first to identify the presence of a specific type of antibody, called anti-citrullinated protein autoantibodies, or ACPAs, in human tear fluid. They are also the first to demonstrate that patients with dry eye disease experienced reduced signs and symptoms of the condition in response to a new eye drop treatment -- made from pooled human antibodies -- that targets ACPAs.
From today’s perspective, the idea of computer systems that track our tiniesteye movements may seem like a far-off futurist’s dream.
More than 25,000 are expected to attend the American Academy of Ophthalmology’s 123rd annual meeting, AAO 2019, from Oct. 12-15 at the Moscone Center in San Francisco.
Staggering new statistics released by the World Health Organization (WHO) in its first World Report on Vision estimate more than 1 billion people are visually impaired because they don’t get the care they need—a finding that brings renewed urgency for sustainable global outreach efforts. The statistics underscore the need for programs like the donor-funded John A. Moran Eye Center Global Outreach Division at the University of Utah, which works to create sustainable eye care systems in developing nations and to reach underserved populations in Utah.
Research to Prevent Blindness (RPB) is pleased to announce that RPB Stein Innovation Awardee Gregg Semenza, MD, PhD, at Johns Hopkins University School of Medicine, has been named a winner of the 2019 Nobel Prize in Medicine.
Massachusetts Eye and Ear raised more than 1.3 million at its 10th Annual Sense-ation! Gala on October 7, 2019, at the Westin Boston Waterfront. Guests were treated to a specially-arranged performance from cast members from Disney’s The Lion King, presented by Broadway In Boston.
Two of the world’s largest ophthalmic organizations today announced a new collaboration to help accelerate the growth and success of companies focused on new therapies for eye disorders.
More than 1 billion people worldwide are living with vision impairment because they do not get the care they need for conditions like short and far sightedness
Gregg L. Semenza, M.D., Ph.D., whose discoveries on how cells respond to low oxygen levels have the potential to result in treatments for a variety of illnesses, today was awarded the 2019 Nobel Prize in Physiology or Medicine by the Nobel Assembly at the Karolinska Institutet. He shares the award with scientists William G. Kaelin, Jr., M.D. of the Dana-Farber Cancer Institute and Peter J. Ratcliffe of Oxford University.
A Baylor University researcher’s prototype smartphone app — designed to help parents detect early signs of various eye diseases in their children such as retinoblastoma, an aggressive pediatric eye cancer — has passed its first big test.
Wills Eye Hospital is pleased to announce the opening of the new J. Arch McNamara, MD Ophthalmic Education Center, a transformational destination for global learning and innovation based at Wills Eye Hospital. The Center is named for Dr. J. Arch McNamara, a beloved surgeon on the Wills Retina Service, clinician investigator, educator, and leader in the field, who passed away in 2010.
A smartphone application has been developed that can help parents detect early signs of eye disease by searching their children’s photographs for traces of leukocoria, also known as “white eye.” The prototype app (CRADLE: ComputeR Assisted Detector LEukocoia) was engineered to autonomously search for the disorder in casual photos of children and make them available under a free download called “White Eye Detector.” The free app has been made available for Android and iPhone devices.
In experiments with rats, pigs and monkeys, Johns Hopkins Medicine researchers have developed a way to deliver sight-saving gene therapy to the retina. If proved safe and effective in humans, the technique could provide a new, more permanent therapeutic option for patients with common diseases such as wet age-related macular degeneration (AMD), and it could potentially replace defective genes in patients with inherited retinal disease.
The number of older Americans with low vision is expected to double in the coming years, as more people live longer. The American Academy of Ophthalmology is taking the opportunity of September’s Healthy Aging Month to let people know they can retain their independence and stay safe, despite declining vision.
In its first year of operation, the school-based vision center at PS 188 in Coney Island, Brooklyn, provided prescription eyeglasses to nearly half of the 314 students evaluated—at no out-of-pocket cost to families.
University of Michigan Kellogg Eye Center is helping to save a child's eyesight with gene therapy.
Seven years ago, Jason Esterhuizen was in a horrific car crash that destroyed his eyes, plunging him into total darkness. Today, he’s regained visual perception and more independence, thanks to an experimental device implanted in his brain by researchers at UCLA Health.
Technical sessions at this year’s conference centered around four thematic areas: Autonomous Systems, Nanophotonics and Plasmonics, Virtual Reality and Augmented Vision, as well as Quantum Technologies.
Scientists have used a microchip to map the back of the eye for disease diagnosis. The interference technology used in the microchip has been around for a little while. This is the first time technical obstacles have been overcome to fabricate a miniature device able to capture high quality images.
A new mathematical model may help doctors learn more about the risk factors and causes of glaucoma, including the mechanisms affecting blood flow to the eye. The research will be presented today at the American Physiological Society (APS) Conference: Interface of Mathematical Models and Experimental Biology: Role of the Microvasculature in Scottsdale, Ariz.
When the world’s newest telescope starts imaging the Southern sky in 2023, it will take photos using optical assemblies designed by Lawrence Livermore National Laboratory researchers and built by Lab industrial partners. A key feature of the camera’s optical assemblies for the Large Synoptic Survey Telescope, under construction in northern Chile, will be its three lenses.
Scientists at the Lowy Medical Research Institute (LMRI) have discovered one cause of a progressive, debilitating eye disease called macular telangiectasia type 2 (MacTel). The work, using genetic, clinical and biochemical studies has implications for other retinal eye diseases, as well as peripheral neuropathies.
Paul S. Bernstein, MD, PhD, spent more than a decade working with families at the John A. Moran Eye Center at the University of Utah on the hunt for the first gene known to cause a rare retinal disease known as MacTel.
The American Academy of Ophthalmology today announced recipients of analytic programs from two funds developed to advance big data investigations of eye disease.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right